SEC Form 4 · accession 0001179110-18-008437
MADRIGAL PHARMACEUTICALS, INC. · MDGL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marc R Schneebaum
Officer — Chief Financial Officer
Period of report
Jun 11, 2018
Accepted (ET)
Jun 13, 2018 · 3:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001157601
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 11, 2018 | M | 5,223 | $99.75 | A | 49,033 | D | |
| Common Stock | Jun 11, 2018 | M | 2,734 | $61.60 | A | 51,767 | D | |
| Common Stock | Jun 11, 2018 | S | 10,099 | $287.46 | D | 41,668 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option | $99.75 | Jun 11, 2018 | M | 5,223 | D | Dec 8, 2015 | Dec 8, 2024 | Common Stock | 5,223 | 1,205 | D |
| Stock Option | $61.60 | Jun 11, 2018 | M | 2,734 | D | Oct 2, 2016 | Oct 2, 2025 | Common Stock | 2,734 | 1,640 | D |